Validation of the National Lung Cancer Audit database and analysis of the information it contains

QR Code

Validation of the National Lung Cancer Audit database and analysis of the information it contains

Introduction Lung cancer is the commonest cause of cancer related death in men and women in England. In 2004 the National Lung Cancer Audit (NLCA) was created, as a national non-mandatory contemporary dataset of clinical features of individuals with lung cancer in part to identify variations in c...

Full description

Bibliographic Details
Main Author:	Rich, Anna
Format:	Thesis (University of Nottingham only)
Language:	English
Published:	2012
Subjects:	Datasets Access to lung cancer treatment Case ascertainment Lung cancer statistics
Online Access:	https://eprints.nottingham.ac.uk/29747/

Similar Items

Quantifying important risk factors and survival following treatment in people with lung cancer using routinely collected national data
by: Powell, Helen.
Published: (2014)

Formulation and optimization of nanoemulsion containing gemcitabine for lung cancer treatment
by: Wahgiman, Nadiatul Atiqah
Published: (2019)

Which patients are assessed by lung cancer nurse specialists? A national lung cancer audit study of over 128,000 patients across England
by: Khakwani, Aamir, et al.
Published: (2016)

Factors influencing the diagnosis and subsequent prognosis in patients with lung cancer
by: O'Dowd, Emma Louise
Published: (2017)

Lung cancer diagnosed following an emergency admission: mixed methods study of the management, outcomes and needs and experiences of patients and carers
by: Wilcock, Andrew, et al.
Published: (2016)

Lung cancer stage-shift following a symptom awareness campaign
by: Kennedy, Martyn, et al.
Published: (2018)

An investigation into treatment administration and survival for people with small cell lung cancer
by: Jones, Gavin Stewart
Published: (2019)

What characteristics of primary care and patients are associated with early death in patients with lung cancer in the UK?
by: O'Dowd, Emma L., et al.
Published: (2015)

Factors surrounding treatment decisions in non-small cell lung cancer
by: Morgan, Helen
Published: (2024)

OA 06.08 Is Lung Cancer Screening Associated with a Negative Psychological Impact?
by: Clark, Marcia, et al.
Published: (2017)

Counting the costs of cancer care: breast, cervical and lung cancer in Trent
by: Wolstenholme, Jane
Published: (2001)

Significance of subcentimetre 18F-FDG PET/CT pulmonary abnormality in patients with known extrapulmonary malignancy.
by: Ahmad Saad , Fathinul Fikri, et al.
Published: (2010)

Docetaxel-loaded magnetic nanostructured lipid carrier functionalized with fish oil-coated iron oxide nanoparticles intended for lung cancer treatment
by: Idris, Auni Hamimi
Published: (2021)

Study on Liposomes Integrity and Delivery of siRNA to Lung Cancer
by: Aljasser, Abdullah
Published: (2024)

Plasma lipid biomarker signatures in squamous carcinoma and adenocarcinoma lung cancer patients
by: Ravipati, Srinivasarao, et al.
Published: (2015)

Theranostic tools against lung and breast cancers : through the lens of mature gold nanoparticles and emerging graphene
by: Baskaran, Savuntherii, et al.
Published: (2024)

Within and between day repeatability of the incremental shuttle walking test in patients with thoracic cancer
by: Wilcock, Andrew, et al.
Published: (2018)

Building an ex vivo model of breast cancer lung metastasis
by: Grey, James F.E.
Published: (2019)

Factors influencing treatment selection and thirty-day mortality following chemotherapy for people with small cell lung cancer: an analysis of national audit data
by: Jones, Gavin S., et al.
Published: (2018)

The emotional impact of screening for lung cancer
by: Bedford, Laura Elizabeth
Published: (2017)

Lung cancer CT screening: psychological responses in the presence and absence of pulmonary nodules
by: Clark, Marcia E., et al.
Published: (2018)

MA 18.04 Changes in smoking behavior in the Early Cancer Detection Test Lung Cancer Scotland (ECLS) Study
by: Young, Ben, et al.
Published: (2017)

Predicting death from surgery for lung cancer: a comparison of two scoring systems in two European countries
by: O'Dowd, Emma L., et al.
Published: (2016)

Homing peptides (rgd/irgd) functionalized zeolitic imidazolate framework-8 for targeted delivery of gemcitabine to lung cancer cell
by: Mohd Abdul Kamal, Nurul Akmarina
Published: (2022)

Anti-tumour efficacy of human mesenchymal stem cell expressing trail on lung cancer cell lines-derived cancer stem cell
by: Shaik M Fakiruddin, Shaik Ahmad Kamal
Published: (2021)

Can body composition be used to optimize the dose of platinum chemotherapy in lung cancer? A feasibility study
by: Crosby, Vincent, et al.
Published: (2016)

Tissue characterisation by Raman spectroscopies
by: Bourbousson, Manon Fanny
Published: (2020)

Application of autoantibody binding curve characteristics and machine learning methods for improving the diagnostic performance of an early detection test for lung cancer
by: Allen, Jared
Published: (2023)

Lung cancer in United Kingdom general practice and the possibility of developing an early warning score
by: Iyen-Omofoman, Barbara
Published: (2012)

Facilitating early diagnosis of lung cancer amongst primary care patients: the views of GPs
by: Wagland, R., et al.
Published: (2017)

Is clarithromycin a potential treatment for cachexia in people with lung cancer?: a feasibility study
by: Awan, Sarah, et al.
Published: (2017)

P3.06-009 How does screening for the early detection of lung cancer facilitate smoking cessation?: a qualitative study of screened smokers
by: Young, Ben, et al.
Published: (2017)

Identification of differentially regulated genes in breast (MCF-7) and lung (H1299) cancer cell lines during Newcastle disease virus strain AF2240 infection
by: Roslan, Nurhidayah
Published: (2012)

Risk of venous thromboembolism in people with lung cancer: a cohort study using linked UK healthcare data
by: Walker, Alex J., et al.
Published: (2016)

Greenly synthesised biocompatible graphene/zirconia nanocomposite: towards the development of a biosensor for the detection of lung cancer biomarkers
by: Lin, Lih Poh
Published: (2022)

Biological Evaluation of Synergistic Drug Combinations, Design and Synthesis of Potent and Selective PI3K Inhibitors and the Design of Bifunctional Ligands Incorporating Pictilisib & Ceritinib for the Treatment of EML4-ALK Positive Lung Cancer
by: Garces, Aimie E.
Published: (2019)

The impact of the ‘hub and spoke’ model of care for lung cancer and equitable access to surgery
by: Khakwani, Aamir, et al.
Published: (2014)

Adrenergic blockers and the risk for common solid cancers: a case-control study
by: Numbere, Beade, et al.
Published: (2017)

Participation in a randomised controlled feasibility study of a complex intervention for the management of the Respiratory Symptom Distress Cluster in lung cancer: patient, carer and research staff views
by: Bailey, Christopher, et al.
Published: (2017)

Coping with and factors impacting upon the experience of lung cancer in patients and primary carers
by: Ellis, J., et al.
Published: (2012)